ArticleActa biochimica et biophysica Sinica2025

VSIG2 hinders gastric cancer progression by suppressing ANXA2-mediated NF-κB pathway activation.

Qingfeng Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.